Jenburkt Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE354A01013
  • NSEID:
  • BSEID: 524731
INR
1,070.50
7.8 (0.73%)
BSENSE

Aug 11

BSE+NSE Vol: 1.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 134395,
    "name": "Jenburkt Pharma",
    "stock_name": "Jenburkt Pharma",
    "full_name": "Jenburkt Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/jenburkt-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,070.50",
    "chg": 7.8,
    "chgp": "0.73%",
    "dir": 1,
    "prev_price": "1,062.70",
    "mcapval": "472.44 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524731,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE354A01013",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "1.25 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/jenburkt-pharma-134395-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-market-signals-4000004",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_technicaldot_4000004.png",
        "date": "2026-05-20 08:00:21",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum. After a period of mild bearishness, the stock’s technical indicators now suggest a sideways trend, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide a comprehensive view for investors."
      },
      {
        "title": "Jenburkt Pharmaceuticals Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/jenburkt-pharmaceuticals-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3997682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/JenburktPharmac_technicaldot_3997682.png",
        "date": "2026-05-19 08:00:26",
        "description": "Jenburkt Pharmaceuticals Ltd., a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a notable shift in its technical momentum. After a period of sideways movement, the stock’s technical parameters now indicate a mildly bearish trend, reflecting a complex interplay of bullish and bearish signals across key indicators such as MACD, RSI, Bollinger Bands, and moving averages. This article analyses these technical developments in detail, contextualising them within the stock’s recent price action and broader market performance."
      }
    ],
    "total": 15,
    "sid": "134395",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/jenburkt-pharmaceuticals-134395"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "Newspaper Publication for standalone Unaudited Financial Results for the quarter ended on 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Standalone Unaudited Financial Results For The Quarter Ended On 30Th June 2026.",
      "datetime": "06-Aug-2026",
      "details": "Standalone Unaudited Financial Results for the quarter ended on 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 06Th August 2026.",
      "datetime": "06-Aug-2026",
      "details": "Outcome of the Board Meeting held today on 06th August 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Jenburkt Pharmaceuticals Ltd. has declared <strong>180%</strong> dividend, ex-date: 11 Jul 25",
          "dt": "2025-07-11",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Aug-2026 | Source : BSE

Newspaper Publication for standalone Unaudited Financial Results for the quarter ended on 30th June 2026.

Standalone Unaudited Financial Results For The Quarter Ended On 30Th June 2026.

06-Aug-2026 | Source : BSE

Standalone Unaudited Financial Results for the quarter ended on 30th June 2026.

Board Meeting Outcome for Outcome Of The Board Meeting Held Today On 06Th August 2026.

06-Aug-2026 | Source : BSE

Outcome of the Board Meeting held today on 06th August 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Jenburkt Pharmaceuticals Ltd. has declared 180% dividend, ex-date: 11 Jul 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available